Delivery Order SPE2DR25D3101-SPE2DR26F5M93
Award Date 11/17/25
Potential Completion Date 11/18/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,219.89 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on July 25, 2025. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, asthma, and...
- The Defense Logistics Agency awarded a $23,749.65 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Dupixent 300 mg/2 ml pens (2 ml vials). This competitively awarded, firm fixed-price contract is scheduled for completion by November 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly prescribed for moderate-to-severe atopic dermatitis, eosinophilic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,981.84 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on October 29, 2025. This non-competitive delivery order, classified as firm fixed price, is set to be completed by October 30, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, asthma, and...
- The Defense Logistics Agency awarded a delivery order valued at $22,237.80 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on August 21, 2025. This firm fixed-price, non-competitive set-aside contract is scheduled for completion by August 22, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly prescribed for moderate-to-severe atopic dermatitis,...
- The Defense Logistics Agency awarded a $60,018.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens. This non-competitive, competitively awarded delivery order is scheduled for completion by September 23, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,279.86 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on July 16, 2025, with a completion date of July 17, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions, including...
- The Defense Logistics Agency awarded a $28,516.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL units). This is a non-set-aside award with an ultimate completion date of September 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat conditions including atopic dermatitis, eosinophilic asthma, and chronic...
- The Defense Logistics Agency awarded a delivery order valued at $11,823.41 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price, non-set-aside contract will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis,...
- The Defense Logistics Agency awarded a $22,121.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens (2 mL quantity) on September 10, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic immunosuppressant medication used to treat moderate-to-severe atopic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $74,194.57 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various allergic and...